IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that Rajesh C. Shrotriya, MD, Chairman of the Board, Chief Executive Officer, and President, will ring the Nasdaq Stock Market opening bell on Tuesday, September 28, 2010.
